MIVI Neuroscience

About:

MIVI Neuroscience focuses on the development and commercialization of clinical solutions for neurointerventional procedures.

Website: https://www.mivineuro.com/

Top Investors: Deerfield, Perceptive Advisors, Concord Health Partners, Aphelion Capital

Description:

MIVI Neuroscience focuses on the development and commercialization of clinical solutions for neurointerventional procedures. Their innovative product portfolio provides physicians with unique devices that improve patient outcomes by reducing complications, shortening procedure times, and expanding treatment to more patients. The company was founded in 2013 and is headquartered in Eden Prairie, Minnesota.

Total Funding Amount:

$92.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Eden Prairie, Minnesota, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)mivineuro.com

Founders:

Matthew Ogle

Number of Employees:

1-10

Last Funding Date:

2021-01-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai